Defence Therapeutics Inc. (DTC) — Cash Flow Reinvestment Rate
Latest as of September 2024:
0.00x
Defence Therapeutics Inc. (DTC) has a Cash Flow Reinvestment Rate of 0.00x as of September 2024, reinvesting €0.00 (capex €0.00 ) from operating cash flow of €87.41K. Explore Defence Therapeutics Inc. cash flow conversion to assess how effectively this company generates cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
€0.00
Capex + Investments
Operating Cash Flow
€87.41K
EUR
Capital Expenditures
€0.00
EUR
Annual Cash Flow Reinvestment Rate for Defence Therapeutics Inc. (None–None)
Year-by-year capital reinvestment analysis for Defence Therapeutics Inc.. For live market cap and broader valuation context, see Defence Therapeutics Inc. market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow